GORAB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.648200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.502800E-01
Normal-vs-Stage2
9.705800E-02
Normal-vs-Stage3
3.103600E-02
Normal-vs-Stage4
8.895200E-01
Stage1-vs-Stage2
6.727600E-01
Stage1-vs-Stage3
3.077000E-01
Stage1-vs-Stage4
5.767600E-01
Stage2-vs-Stage3
2.159000E-01
Stage2-vs-Stage4
5.008600E-01
Stage3-vs-Stage4
2.500000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.170000E-02
Normal-vs-AfricanAmerican
4.282400E-01
Normal-vs-Asian
2.151800E-01
Caucasian-vs-AfricanAmerican
4.005800E-01
Caucasian-vs-Asian
6.467600E-01
AfricanAmerican-vs-Asian
7.286400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.242590E-01
Normal-vs-Female
7.629700E-02
Male-vs-Female
6.980600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.965500E-02
Normal-vs-Age(41-60Yrs)
1.355590E-01
Normal-vs-Age(61-80Yrs)
8.903800E-02
Normal-vs-Age(81-100Yrs)
1.883950E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.529800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.068800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.777600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.288800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.849000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.098600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.445800E-02
Normal-vs-Daily Drinker
3.819700E-03
Normal-vs-Weekly Drinker
1.326010E-01
Normal-vs-Occasional Drinker
2.076800E-01
Normal-vs-Social Drinker
3.052400E-02
Non Drinker-vs-Daily Drinker
9.517300E-03
Non Drinker-vs-Weekly Drinker
7.889600E-01
Non Drinker-vs-Occasional Drinker
6.139000E-01
Non Drinker-vs-Social Drinker
8.506400E-01
Daily Drinker-vs-Weekly Drinker
7.352000E-02
Daily Drinker-vs-Occasional Drinker
8.023000E-03
Daily Drinker-vs-Social Drinker
2.277700E-02
Weekly Drinker-vs-Occasional Drinker
5.384800E-01
Weekly Drinker-vs-Social Drinker
9.193800E-01
Occasional Drinker-vs-Social Drinker
5.282600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.063610E-01
Normal-vs-Grade 2
4.076800E-03
Normal-vs-Grade 3
2.554100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.555800E-01
Grade 1-vs-Grade 3
1.884230E-01
Grade 1-vs-Grade 4
1.063610E-01
Grade 2-vs-Grade 3
3.281000E-01
Grade 2-vs-Grade 4
4.076800E-03
Grade 3-vs-Grade 4
2.554100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.798190E-02
Normal-vs-NonDiabetic
7.900200E-02
Diabetic-vs-NonDiabetic
1.005020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.937800E-03
Normal-vs-NoPancreatitis
5.944200E-02
Pancreatitis-vs-NoPancreatitis
1.066840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.819400E-01
Normal-vs-N1
7.715500E-02
N0-vs-N1
6.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.379400E-01
Normal-vs-TP53-NonMutant
2.481400E-01
TP53-Mutant-vs-TP53-NonMutant
4.374000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
